Hot Listing
Mohs & Derm Practice | Coastal CT | ~$1.9M SDE | Independent
Share on Facebook 
Post to X 
Share on LinkedIn 
Share on Reddit Business Description
Mohs Surgery & Dermatology | Southeastern CT
A 20-year-old, fully independent Mohs surgery and medical dermatology practice in coastal southeastern Connecticut is available for acquisition. Offered at $4,400,000 — approximately 2.3x a normalized Seller’s Discretionary Earnings (SDE) of $1,887,364 (the four-year average SDE adjusted for 3% 2026 growth).
This is a direct-to-physician opportunity — not structured for private equity, MSOs, or financial acquirers. The ideal buyer is a fellowship-trained Mohs surgeon or board-certified dermatologist ready to own and operate an established, fully operational practice in one of coastal New England’s most desirable communities. A board-certified dermatologist who is not personally Mohs-fellowship-trained may also acquire the practice, provided they employ a fellowship-trained Mohs surgeon to perform the Mohs caseload.
KEY METRICS:
• Asking Price: $4,400,000 (~2.3x normalized SDE)
• Normalized SDE: $1,887,364 (4-yr avg + 3% growth)
• $4,000,000 cash at close; $400,000 seller financing for qualified physician buyers
• 16,820 annual encounters | 11,150 established patients | 1,000–1,200 Mohs cases/yr
• Avg base collections/encounter: $398 | Payer mix: 62% Medicare, 34% commercial — no Medicaid
• Google rating: 4.7 / 5.0 | Founded 2006
2025 REVENUE NOTE:
2025 included a non-recurring skin-substitute (placental allograft) revenue stream the practice is discontinuing in 2026 due to Medicare reimbursement changes. The valuation deliberately normalizes this out; buyers should model from normalized SDE, not 2025 reported figures. Full detail provided under NDA.
WHAT YOU’RE ACQUIRING:
Three experienced providers — a fourth joining mid-2026 — all expected to remain post-sale. PA-Cs generate 55–60% of base net collections through medical dermatology, biopsies, and procedures, feeding Mohs cases directly to the physician-owner. This built-in referral engine reduces key-person risk and supports a full schedule from day one. Full procedural breadth: Mohs micrographic surgery, CLIA-certified in-office histopathology lab, excisions, biopsies, cryotherapy, allergy patch testing, SRT, ALA photodynamic therapy, and cosmetic Botox. The incoming physician steps into a complete clinical infrastructure — no build phase, no rebranding, no stabilization period.
FINANCING: Conventional medical practice financing at competitive rates (currently sub-6%, 15-year amortization) for qualified physician buyers; SBA 7(a) also available; $400,000 seller financing.
Exclusively represented by Strategic Medical Brokers | 888-970-1210 | strategicmedicalbrokers.com
This is a direct-to-physician opportunity — not structured for private equity, MSOs, or financial acquirers. The ideal buyer is a fellowship-trained Mohs surgeon or board-certified dermatologist ready to own and operate an established, fully operational practice in one of coastal New England’s most desirable communities. A board-certified dermatologist who is not personally Mohs-fellowship-trained may also acquire the practice, provided they employ a fellowship-trained Mohs surgeon to perform the Mohs caseload.
KEY METRICS:
• Asking Price: $4,400,000 (~2.3x normalized SDE)
• Normalized SDE: $1,887,364 (4-yr avg + 3% growth)
• $4,000,000 cash at close; $400,000 seller financing for qualified physician buyers
• 16,820 annual encounters | 11,150 established patients | 1,000–1,200 Mohs cases/yr
• Avg base collections/encounter: $398 | Payer mix: 62% Medicare, 34% commercial — no Medicaid
• Google rating: 4.7 / 5.0 | Founded 2006
2025 REVENUE NOTE:
2025 included a non-recurring skin-substitute (placental allograft) revenue stream the practice is discontinuing in 2026 due to Medicare reimbursement changes. The valuation deliberately normalizes this out; buyers should model from normalized SDE, not 2025 reported figures. Full detail provided under NDA.
WHAT YOU’RE ACQUIRING:
Three experienced providers — a fourth joining mid-2026 — all expected to remain post-sale. PA-Cs generate 55–60% of base net collections through medical dermatology, biopsies, and procedures, feeding Mohs cases directly to the physician-owner. This built-in referral engine reduces key-person risk and supports a full schedule from day one. Full procedural breadth: Mohs micrographic surgery, CLIA-certified in-office histopathology lab, excisions, biopsies, cryotherapy, allergy patch testing, SRT, ALA photodynamic therapy, and cosmetic Botox. The incoming physician steps into a complete clinical infrastructure — no build phase, no rebranding, no stabilization period.
FINANCING: Conventional medical practice financing at competitive rates (currently sub-6%, 15-year amortization) for qualified physician buyers; SBA 7(a) also available; $400,000 seller financing.
Exclusively represented by Strategic Medical Brokers | 888-970-1210 | strategicmedicalbrokers.com
About the Business
- Years in Operation
- 17
- Facilities & Assets
- Freestanding medical/professional office building in coastal southeastern CT. 11,015 sq ft total; 5,192 sq ft clinical space. 7 exam rooms, 6 procedure rooms, 3 provider offices, fully equipped in-office Mohs histology lab, on-site SRT treatment room, 28 dedicated parking spaces. Assumable lease through Oct 2028; one 3-year renewal option.
- Market Outlook / Competition
- Southeastern CT primary catchment: ~283,000 residents; 20% over age 65, 75% white — the highest-risk demographic for skin cancer. Secondary catchment into Westerly, RI (~20,000 residents, 89% white, older skew). Regional consolidation has created a documented specialist shortage; Mohs surgeons now travel between locations to provide coverage. New patient wait times are elevated. Practice accepts 1,070 new patients annually, reflecting both unmet demand and team capacity. Demographic tailwinds are durable.
- Opportunities for Growth
- Fourth PA-C joining mid-2026 — already recruited, no capital required. Full PA schedules confirm demand exceeds provider capacity; 11,015 sq ft facility supports additional providers without renovation. Cosmetic laser services currently referred out — capturable revenue for an owner with laser capability. Affluent, health-conscious coastal patient base is ideal for cosmetic expansion. SRT revenue-sharing partnership optimizable or in-houseable. Website and SEO represent low-cost new patient acquisition opportunity.
Real Estate
- Owned or Leased
- Leased
- Building Sq. Ft.
- 11,015
- Lease Expiration
- 10/31/2028
About the Sale
- Seller Motivation
- Founding physician is relocating family to Southern California.
- Transition Support
- Founding physician committed to a structured transition — duration and compensation by mutual agreement. Will remain in a clinical capacity to support Mohs surgery coverage and patient continuity. PA-Cs, practice manager, and full front office team expected to remain post-sale. FAQ video with seller available to qualified buyers upon request.
- Financing Options
- $400,000 seller financing available to qualified physician buyers
Listing Info
- ID
- 2513831
- Listing Views
- 271
Listing ID: 2513831 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.
Businesses for SaleConnecticut Businesses for SaleConnecticut Health & Medical Businesses for SaleConnecticut Medical Practices Businesses for Sale
Similar Listings
